Interestingly, we found that both neutrophils from healthy donors and SLE patients similarly respond to R837 in terms of CXCL8 production, but only if the TLR7 agonist was used at 25–50 μM. This evidence concerns the gene TLR7 and systemic lupus erythematosus.